418 related articles for article (PubMed ID: 16291771)
1. New progestagens for contraceptive use.
Sitruk-Ware R
Hum Reprod Update; 2006; 12(2):169-78. PubMed ID: 16291771
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of different progestogens: the special case of drospirenone.
Sitruk-Ware R
Climacteric; 2005 Oct; 8 Suppl 3():4-12. PubMed ID: 16203650
[TBL] [Abstract][Full Text] [Related]
3. New progestogens: a review of their effects in perimenopausal and postmenopausal women.
Sitruk-Ware R
Drugs Aging; 2004; 21(13):865-83. PubMed ID: 15493951
[TBL] [Abstract][Full Text] [Related]
4. The use of newer progestins for contraception.
Sitruk-Ware R; Nath A
Contraception; 2010 Nov; 82(5):410-7. PubMed ID: 20933114
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of progestins.
Sitruk-Ware R
Maturitas; 2004 Apr; 47(4):277-83. PubMed ID: 15063480
[TBL] [Abstract][Full Text] [Related]
6. Fourth-Generation Progestins Inhibit 3β-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids.
Louw-du Toit R; Perkins MS; Snoep JL; Storbeck KH; Africander D
PLoS One; 2016; 11(10):e0164170. PubMed ID: 27706226
[TBL] [Abstract][Full Text] [Related]
7. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effects of contraceptive steroids.
Sitruk-Ware R; Nath A
Rev Endocr Metab Disord; 2011 Jun; 12(2):63-75. PubMed ID: 21538049
[TBL] [Abstract][Full Text] [Related]
9. [Third generation progestagens].
Belaisch J; Eliakim V
Contracept Fertil Sex (Paris); 1993 Apr; 21(4):287-93. PubMed ID: 12318226
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat.
Shirk RA; Zhang Z; Winneker RC
J Steroid Biochem Mol Biol; 2005 Mar; 94(4):361-8. PubMed ID: 15857755
[TBL] [Abstract][Full Text] [Related]
12. Nomegestrol acetate: steroid receptor transactivation profile in Chinese hamster ovary cells and ovulation inhibition in rat and monkey.
van Diepen HA; Lam TW; Kuil CW
Contraception; 2011 Aug; 84(2):199-204. PubMed ID: 21757063
[TBL] [Abstract][Full Text] [Related]
13. Nomegestrol acetate, a novel progestogen for oral contraception.
Mueck AO; Sitruk-Ware R
Steroids; 2011 May; 76(6):531-9. PubMed ID: 21335021
[TBL] [Abstract][Full Text] [Related]
14. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
15. [Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Apr; 16(4 Suppl):1-8. PubMed ID: 12342078
[TBL] [Abstract][Full Text] [Related]
16. [Side effects of third generation progestagens].
Sitruk-ware R
Contracept Fertil Sex (Paris); 1993 Apr; 21(4):295-300. PubMed ID: 12318229
[TBL] [Abstract][Full Text] [Related]
17. An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells.
Shields-Botella J; Duc I; Duranti E; Puccio F; Bonnet P; Delansorne R; Paris J
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):111-22. PubMed ID: 14672731
[TBL] [Abstract][Full Text] [Related]
18. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
Lete I; Chabbert-Buffet N; Jamin C; Lello S; Lobo P; Nappi RE; Pintiaux A
Eur J Contracept Reprod Health Care; 2015; 20(5):329-43. PubMed ID: 26007631
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of progestins.
Sitruk-Ware R
Maturitas; 2008; 61(1-2):151-7. PubMed ID: 19434887
[TBL] [Abstract][Full Text] [Related]
20. Nestorone: a progestin with a unique pharmacological profile.
Kumar N; Koide SS; Tsong Y; Sundaram K
Steroids; 2000; 65(10-11):629-36. PubMed ID: 11108869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
